NCT07330960

Brief Summary

The purpose of this study is to strengthen the normative QbMobile data for children and adolescents age 6-11 years to allow for a more robust and accurate representation when comparing a patient's QbMobile performance with the appropriate normative reference group.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Jan 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Jan 2026Jan 2027

First Submitted

Initial submission to the registry

December 11, 2025

Completed
21 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 9, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

January 9, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

December 11, 2025

Last Update Submit

December 29, 2025

Conditions

Keywords

Healthy Volunteer

Outcome Measures

Primary Outcomes (1)

  • Establishment of Normative Statistics for QbMobile Performance

    Normative data will be analyzed to generate Standard Deviation (SD) scores and Total Scores for four domains: activity, impulsivity, inattention, and movement patterns. QbMobile SD-scores are standardized metrics derived from the main parameters (attention, impulsivity, activity and movement). These scores are calculated using and age and sex at birth adjusted normative dataset. The QbMobile also produces a Total Score number ranging from 0 to 100, where 0 indicates a low likelihood of exhibiting ADHD symptoms and 100 indicates a high likelihood of exhibiting ADHD symptoms. These scores will enable individual test performance to be expressed relative to normative benchmarks.

    1 QbMobile test at the clinic visit (Day 1)

Secondary Outcomes (1)

  • Exploratory Analysis of Additional Domain Parameters

    1 QbMobile test at the clinic visit (Day 1)

Study Arms (1)

Healthy Volunteers

Device: Digital software application for cognitive performance and activity measurement (QbMobile, investigational device)

Interventions

Participants will complete a non-invasive, 10-minute digital tests using the QbMobile Investigational Device. The test objectively measure cognitive performance and activity levels.

Healthy Volunteers

Eligibility Criteria

Age6 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of a community-based sample of healthy children aged 6 to 11 years with no history of ADHD. Participants are primarily identified through local schools, community youth organizations, and general practitioners, with additional participants identified through the general patient databases of participating clinical sites.

You may qualify if:

  • Provide informed consent from parent/legal guardians and assent for all study participants for the QbMobile study;
  • Aged \> 6 years and \< 11 years old;
  • Have no documented or suspected current or lifetime diagnosis of ADHD;
  • Have adequate sensory and physical ability to complete QbMobile;

You may not qualify if:

  • Intellectual disability designated by IQ\<75;
  • Has a concurrent medical diagnosis that could significantly affect test performance such as brain injuries, Parkinson's disease, current epilepsy or active seizures, amyotrophic lateral sclerosis (ALS), multiple sclerosis, dementias (e.g. vascular dementia, Alzheimer disease), unmanaged psychiatric illness;
  • Has other conditions that could affect test performance (migraine or other types of severe headache, chronic or acute pain);
  • Substance use (e.g., alcohol, drugs) that may affect performance on the day of the tests.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Ragini Sanyal

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2025

First Posted

January 9, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Last Updated

January 9, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Due to the nature of the research, limited access to supporting data may be granted upon reasonable request under confidentiality agreements from the corresponding sponsor.